Carlton Lawson - 23 Aug 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Group President EMEA
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Issuer symbol
KVUE
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
4
Filing time
25 Aug 2023, 17:59:56 UTC
Previous filing
08 May 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Other $0 +1,670 $0.000000 1,670 23 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Award $0 +13,557 $0.000000 13,557 23 Aug 2023 Common Stock 13,557 Direct F2, F3
transaction KVUE Restricted Stock Units Award $0 +11,846 $0.000000 11,846 23 Aug 2023 Common Stock 11,846 Direct F2, F4
transaction KVUE Restricted Stock Units Award $0 +3,119 $0.000000 3,119 23 Aug 2023 Common Stock 3,119 Direct F2, F5
transaction KVUE Restricted Stock Units Award $0 +34,907 $0.000000 34,907 23 Aug 2023 Common Stock 34,907 Direct F6, F7
transaction KVUE Restricted Stock Units Award $0 +29,618 $0.000000 29,618 23 Aug 2023 Common Stock 29,618 Direct F4, F6
transaction KVUE Restricted Stock Units Award $0 +9,949 $0.000000 9,949 23 Aug 2023 Common Stock 9,949 Direct F5, F6
transaction KVUE Stock Options Award $0 +31,173 $0.000000 31,173 23 Aug 2023 Common Stock 31,173 $20.44 Direct F8, F9
transaction KVUE Stock Options Award $0 +34,225 $0.000000 34,225 23 Aug 2023 Common Stock 34,225 $22.23 Direct F5, F8
transaction KVUE Stock Options Award $0 +117,012 $0.000000 117,012 23 Aug 2023 Common Stock 117,012 $22.40 Direct F4, F8
transaction KVUE Stock Options Award $0 +112,197 $0.000000 112,197 23 Aug 2023 Common Stock 112,197 $21.97 Direct F3, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.
F2 These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
F3 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.
F4 This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date.
F5 This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date.
F6 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
F7 This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date.
F8 These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.
F9 This award is fully vested